| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $14.6M | -54.3% |
| SG&A Expense | $10.6M | -20.6% |
| Operating Income | -$25.2M | +44.4% |
| Pre-tax Income | -$32.1M | +37.9% |
| Income Tax | -$1.8M | +0.0% |
| Net Income | -$32.1M | +35.7% |
| EPS (Basic) | -$6.01 | -413.7% |
| EPS (Diluted) | -$6.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.1M | -40.6% |
| Current Assets | $40.2M | -35.4% |
| Total Assets | $55.1M | -28.6% |
| Current Liabilities | $1.4M | -51.1% |
| Total Liabilities | $75.1M | +8.6% |
| Stockholders' Equity | -$20.0M | -351.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.6M | -0.2% |
| Capital Expenditures | $16K | — |
| Investing Cash Flow | -$16K | — |
| Financing Cash Flow | -$5 | -100.0% |
| Free Cash Flow | -$24.7M | — |
| -413.7% |